Current UrologyPub Date : 2025-01-01Epub Date: 2024-11-14DOI: 10.1097/CU9.0000000000000263
Sentai Ding, Chenrui Wu, Jishuang Cao, Jiaju Lyu
{"title":"Immune checkpoint inhibitor therapy as a neoadjuvant treatment for muscle-invasive bladder carcinoma: A narrative review.","authors":"Sentai Ding, Chenrui Wu, Jishuang Cao, Jiaju Lyu","doi":"10.1097/CU9.0000000000000263","DOIUrl":"https://doi.org/10.1097/CU9.0000000000000263","url":null,"abstract":"<p><p>Immunotherapy has become a standard treatment for patients with advanced urothelial carcinoma, and neoadjuvant immunotherapy is currently being extensively explored. This review highlights the initial findings and key clinical therapeutic insights on immune checkpoint inhibitors in the early treatment of muscle-invasive bladder cancer across diverse patient populations. Most available literature consists of clinical investigations involving small sample, single-arm phase II trials, with the primary endpoint being the pathologic complete response rate. Early results of immune checkpoint inhibitors in the neoadjuvant treatment of bladder cancer have demonstrated promising efficacy. However, these findings require confirmation in large phase III clinical trials, with particular emphasis on long-term survival benefits and identifying patients who respond to treatment.</p>","PeriodicalId":39147,"journal":{"name":"Current Urology","volume":"19 1","pages":"39-42"},"PeriodicalIF":0.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12042169/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144048811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A comprehensive visual report of urodynamic study in rats with spinal cord injury.","authors":"Hanieh Salehi-Pourmehr, Javad Mahmoudi, Arman Saeedi Vahdat, Sakineh Hajebrahimi, Nasrin Abolhasanpour","doi":"10.1097/CU9.0000000000000150","DOIUrl":"10.1097/CU9.0000000000000150","url":null,"abstract":"<p><strong>Objectives: </strong>Spinal cord injury (SCI) is one of the most debilitating and expensive traumatic conditions. Chronic complications after SCI have a particularly negative impact on patients' functional independence and quality of life. Urodynamic study (UDS) provides a quantitative assessment of lower urinary tract function in these patients. In many fields, animal models are considered a precursor to clinical trials, so research using laboratory animals play a major role in knowledge acquisition.</p><p><strong>Materials and methods: </strong>Twelve female Wistar rats (13 weeks old, 220-270 g) were divided randomly into 2 groups: sham or SCI. The sham-operated group underwent a laminectomy at T9-T10 without any spinal cord damage, while the SCI group underwent a complete transection at the T9-T10 vertebral level. We performed cystometry in all animals at the end of the fourth week. In this article, we visualize all procedures for catheter implementation and UDS in animals for the first time at Tabriz University of Medical Sciences, Iran, using a locally developed animal UDS device.</p><p><strong>Results: </strong>The UDS results showed that the bladders in the SCI group were overactive and that peak and baseline pressures increased significantly in rats with SCI when compared with the sham group (<i>p</i> < 0.05 for all). Conversely, significant reductions in bladder compliance and intercontraction interval were observed in the SCI group (<i>p</i> < 0.05 for both).</p><p><strong>Conclusions: </strong>This comprehensive visual report will be very useful to all researchers in the field of urology. Furthermore, the measurable variables of the UDS device have been described in this study.</p>","PeriodicalId":39147,"journal":{"name":"Current Urology","volume":" ","pages":"59-63"},"PeriodicalIF":0.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12042172/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43675254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Current UrologyPub Date : 2025-01-01Epub Date: 2024-09-27DOI: 10.1097/CU9.0000000000000259
Qun Wang, Wenkai Xu, Lu Ying, Hongjin Shi, Yuxin Sun, Wei Feng, Haole Xu, Jun Xie, Hairong Wei, Zhao Yang, Haifeng Wang
{"title":"Preliminary study of the mechanism of isolinderalactone inhibiting the malignant behavior of bladder cancer.","authors":"Qun Wang, Wenkai Xu, Lu Ying, Hongjin Shi, Yuxin Sun, Wei Feng, Haole Xu, Jun Xie, Hairong Wei, Zhao Yang, Haifeng Wang","doi":"10.1097/CU9.0000000000000259","DOIUrl":"https://doi.org/10.1097/CU9.0000000000000259","url":null,"abstract":"<p><strong>Background: </strong>Isolinderalactone (ILL), extracted from the dried tubers of <i>Linderae aggregate,</i> has multiple functions, such as antioxidation, antitumor, and anti-infection effects. However, there have been few studies on ILL's antitumor role and no reports on its role in bladder cancer (BC).</p><p><strong>Materials and methods: </strong>Human BC cell lines T24 and EJ-1 were treated with different concentrations of ILL (0, 10, 20, 50, 100, 200, 400, 600, 800, and 1000 μmol/L), and the cell proliferation inhibition rate was analyzed using the CCK-8 assay. The effect of ILL on T24 and EJ-1 cell cycle inhibition and apoptosis was examined using flow cytometry. Immunoblotting was used to detect the levels of apoptosis-related proteins, BAX, BAK1, and CYCS, in BC cells of the control and ILL-treated groups, and quantitative PCR experiments were performed to detect the apoptosis-related gene expression of <i>CASP10</i>, <i>CYCS</i>, <i>BAX</i>, <i>BCL-2</i>, <i>CASP8</i>, and <i>BAK1</i>. T24 and EJ-1 tumor-bearing mouse models were established and divided into vehicle control, low-dose (10 mg/kg) and high-dose (20 mg/kg) groups, with 5 mice in each group. Hematoxylin and eosin staining and immunohistochemistry were used to detect changes in apoptosis-related proteins in vivo.</p><p><strong>Results: </strong>The CCK-8 assay showed that in vitro, ILL significantly inhibited the proliferation of the T24 and EJ-1 BC cell lines. Flow cytometry and immunoblotting results showed that ILL increased mitochondrial permeability by upregulating proapoptotic proteins BAK1 and BAX, promoting CYCS release and significantly inducing cell cycle arrest at G0/G1 phase. In vivo, on day 25 of administration, tumor inhibition rates in T24 and EJ-1 tumor-bearing mice were up to 75.24% and 47.43%, respectively, in the ILL high-dose-treated and 71.58% and 43.89%, respectively, in the ILL low-dose-treated groups.</p><p><strong>Conclusions: </strong>Isolinderalactone controls BC progression by inducing apoptosis, suggesting that ILL may be an effective drug for the treatment of BC.</p>","PeriodicalId":39147,"journal":{"name":"Current Urology","volume":"19 1","pages":"49-58"},"PeriodicalIF":0.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12042191/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143986794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Ability of clock drawing errors on Mini-Cog test to predict development of delirium after major urological cancer surgery.","authors":"Shugo Yajima, Yasukazu Nakanishi, Shunya Matsumoto, Naoya Okubo, Kenji Tanabe, Madoka Kataoka, Hitoshi Masuda","doi":"10.1097/CU9.0000000000000177","DOIUrl":"10.1097/CU9.0000000000000177","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to evaluate the impact of the clock drawing test (CDT) on postoperative delirium and compare the abilities of the mini-cognitive (Mini-Cog) test and the CDT for predicting postoperative delirium after major urological cancer surgery.</p><p><strong>Materials and methods: </strong>In this single-center retrospective observational study, we collected the medical records of patients who underwent major urologic cancer surgery and preoperative cognitive screening based on the Mini-Cog test consisting of the CDT and the 3-word recall task at our department in 2020-2021 (n = 387). Univariate and multivariate logistic regression analyses were used to identify the clinical risk factors for postoperative delirium. We also compared the ability of the CDT alone and the Mini-Cog test consisting of the CDT and 3-word recall task to predict postoperative delirium.</p><p><strong>Results: </strong>A total of 117 patients (30%) had abnormal CDT results. Postoperative delirium occurred in 29 patients (7%). On multivariate analysis, American Society of Anesthesiologists physical status ≥3 (odds ratio [OR], 5.0; <i>p</i> = 0.01), abnormal CDT (OR, 4.8; <i>p</i> < 0.001), preoperative benzodiazepine use (OR, 4.9; <i>p</i> < 0.001), and operative time ≥237 minutes (OR, 3.0; <i>p</i> = 0.01) were independent risk factors for postoperative delirium. The area under the curve for predicting postoperative delirium was 0.709 for CDT alone and 0.743 for the Mini-Cog test. No significant intergroup difference was observed (<i>p</i> = 0.43).</p><p><strong>Conclusions: </strong>The CDT served as a formal but simple tool with adequate predictive power to identify the risk of postoperative delirium among patients undergoing major urological cancer surgery. Effective screening using the CDT might help provide optimal urological care for older patients.</p>","PeriodicalId":39147,"journal":{"name":"Current Urology","volume":" ","pages":"64-69"},"PeriodicalIF":0.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12042190/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44309131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Current UrologyPub Date : 2025-01-01Epub Date: 2022-03-03DOI: 10.1097/CU9.0000000000000095
Cecile T Pham, Patrick Lau, Jonathan Hew, Christos Apostolou, Amanda Chung
{"title":"Mesenteric misadventure: An unusual suprapubic catheter complication.","authors":"Cecile T Pham, Patrick Lau, Jonathan Hew, Christos Apostolou, Amanda Chung","doi":"10.1097/CU9.0000000000000095","DOIUrl":"10.1097/CU9.0000000000000095","url":null,"abstract":"<p><p>Although suprapubic cystotomy for catheter insertion is commonly performed, complications can be associated with serious morbidity. This case describes delayed recognition of a transperitoneal suprapubic catheter (SPC) traversing the small bowel mesentery and causing a closed loop obstruction of the caecum 7 years after SPC insertion. There are very few cases in the literature of SPC causing mesenteric perforation and to the best of our knowledge, this is the first reported case causing subsequent obstruction of the caecum and the longest delay of 7 years between SPC insertion and manifestation of bowel obstruction.</p>","PeriodicalId":39147,"journal":{"name":"Current Urology","volume":" ","pages":"70-72"},"PeriodicalIF":0.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12042181/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46762898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Current UrologyPub Date : 2025-01-01Epub Date: 2024-09-27DOI: 10.1097/CU9.0000000000000257
Besut Daryanto, Wisnu Syahputra Suryanullah, Probo Yudha Pratama Putra
{"title":"Holmium laser enucleation of the prostate versus transurethral resection of the prostate in treatment of benign prostatic hyperplasia: A meta-analysis of 13 randomized control trials.","authors":"Besut Daryanto, Wisnu Syahputra Suryanullah, Probo Yudha Pratama Putra","doi":"10.1097/CU9.0000000000000257","DOIUrl":"https://doi.org/10.1097/CU9.0000000000000257","url":null,"abstract":"<p><strong>Background: </strong>The prevalence of benign prostatic hyperplasia (BPH) in older men increases with age, beginning at 40-45 years and reaching to 60% by 60 years and 80% by 80 years. Surgical procedures such as holmium laser enucleation of the prostate (HoLEP) and transurethral resection of the prostate (TURP) are the preferred treatments for BPH. Nevertheless, there is disagreement regarding the most efficient and safe treatment for BPH. The objective of this meta-analysis was to assess the efficacy and safety of HoLEP and TURP based on existing evidence.</p><p><strong>Materials and methods: </strong>This meta-analysis was performed in accordance with the PRISMA guidelines. In February 2023, a literature review was conducted using PubMed, ScienceDirect, and the Cochrane Library, and the meta-analysis was performed using RevMan V.5.4.</p><p><strong>Results: </strong>A total of 656 patients underwent HoLEP, and 653 patients underwent TURP. There was no statistically significant difference in the International Prostate Symptom Score at 1 month or at 3, 6, 18, 24, and 36 months; the HoLEP group showed a significant difference at 12 months. The pooled data from the maximum urinary flow rate at 1-12 months revealed no significant findings, but the TURP group showed significant results at 24 months. Meanwhile, the HoLEP group showed significant postvoid residual results. There was no significant difference in the quality of life between the groups. Patients who underwent HoLEP had shorter hospital stay and catheter usage period and had lower hemoglobin drop. The operating time was shorter in the TURP group. The difference in specimen weight between the 2 groups was not statistically significant. The overall complications were similar in both groups, but the HoLEP group received significantly fewer blood transfusions.</p><p><strong>Conclusions: </strong>Holmium laser enucleation of the prostate demonstrated excellent efficacy and safety, with fewer hematological changes and complications; however, TURP had a shorter operating time.</p>","PeriodicalId":39147,"journal":{"name":"Current Urology","volume":"19 1","pages":"6-16"},"PeriodicalIF":0.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12042171/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144040388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Current UrologyPub Date : 2025-01-01Epub Date: 2024-09-27DOI: 10.1097/CU9.0000000000000261
Junhao Xu, Bangmin Han, Shujie Xia, Yifeng Jing
{"title":"Beyond size: A comprehensive overview of small-volume benign prostatic hyperplasia.","authors":"Junhao Xu, Bangmin Han, Shujie Xia, Yifeng Jing","doi":"10.1097/CU9.0000000000000261","DOIUrl":"https://doi.org/10.1097/CU9.0000000000000261","url":null,"abstract":"<p><p>Benign prostatic hyperplasia (BPH) is one of the most frequently diagnosed benign disorders that cause dysuria in middle-aged and elderly men. Some patients with BPH have relatively small prostates (referred to as small-volume BPH) but still experience the lower urinary tract infection. Medication treatment is typically not successful in these patients. In addition, their pathophysiologic pathways deviate from those previously observed. Furthermore, as there is no accepted protocol for the diagnosis and treatment of small-volume BPH, patients can experience great difficulties in managing surgical complications such as bladder neck contracture. Thus, we reviewed the features of small-volume prostates, preoperative assessment, surgical technique, and management of complications.</p>","PeriodicalId":39147,"journal":{"name":"Current Urology","volume":"19 1","pages":"1-5"},"PeriodicalIF":0.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12042193/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144054364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Current UrologyPub Date : 2024-12-01Epub Date: 2024-12-20DOI: 10.1097/CU9.0000000000000215
Amr E Darwish, Alaa E Abdel Moneim, Abdelfatah I Ahmed, Seif M Hamdy, Hassan A Abolella, Ahmed Reda
{"title":"A randomized comparative study of flexible ureterorenoscopy versus mini-percutaneous nephrolithotomy for treatment of renal stones 2 cm or less.","authors":"Amr E Darwish, Alaa E Abdel Moneim, Abdelfatah I Ahmed, Seif M Hamdy, Hassan A Abolella, Ahmed Reda","doi":"10.1097/CU9.0000000000000215","DOIUrl":"10.1097/CU9.0000000000000215","url":null,"abstract":"<p><strong>Background: </strong>Flexible ureterorenoscopy (fURS) and mini-percutaneous nephrolithotomy (mPCNL) have been increasingly used for the treatment of renal stones. However, current guidelines do not recommend one modality over the other. The aim of this study is to compare the safety and efficacy of treatment with fURS versus mPCNL for renal stones sized 2 cm or less.</p><p><strong>Materials and methods: </strong>A prospective, randomized, comparative study was conducted between January 2019 and July 2021 at 3 tertiary care urology centers. Inclusion criteria were adult patients with renal stone(s) ≤ 2 cm with inappropriateness or failure of extracorporeal shock-wave lithotripsy. Subjects were assigned to 1 of 2 treatment groups, either mPCNL or fURS. Two primary outcomes were assessed: (1) initial success rate, defined as the absence of clinically significant residual fragments (>2 mm) on kidney ureter bladder X-ray and ultrasound on the first postoperative day; and (2) complications, which were reported according to the Modified Clavien-Dindo classification system. Secondary outcomes included final success rate, defined as the absence of clinically significant residual fragments on noncontrast computed tomography on the 90th postoperative day; operative time; auxiliary procedures and blood transfusion rates; hemoglobin drop; and length of hospital stay.</p><p><strong>Results: </strong>One hundred and eighteen procedures were analyzed (59 in each group). The initial success rate of the mPCNL group (93%) was significantly higher than that of the fURS group (70%). Complications occurred more frequently with mPCNL than fURS (44.1% vs. 18.6%, respectively). Final success rate, operative time, and length of hospital stay were comparable between the 2 groups.</p><p><strong>Conclusions: </strong>Mini-percutaneous nephrolithotomy is more effective than fURS as a single-step treatment for renal stones <2 cm because of its higher initial success rate and lower auxiliary procedure rate. However, mPCNL results in significantly higher complication rates than fURS.</p>","PeriodicalId":39147,"journal":{"name":"Current Urology","volume":" ","pages":"273-277"},"PeriodicalIF":0.9,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12004952/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45386070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Current UrologyPub Date : 2024-12-01Epub Date: 2024-12-20DOI: 10.1097/CU9.0000000000000065
Ahmed S El-Hefnawy, Mona A El-Hussiny, Ahmed M A Ibrahim, Khadiga M Ali, Mohammed A Atwa, Nashwa Barakat, Mohamed Alhefnawy, Ahmed A Shokeir
{"title":"Is the urinary kidney injury molecule an optimum biomarker for early detection of obstructive nephropathy? An experimental study.","authors":"Ahmed S El-Hefnawy, Mona A El-Hussiny, Ahmed M A Ibrahim, Khadiga M Ali, Mohammed A Atwa, Nashwa Barakat, Mohamed Alhefnawy, Ahmed A Shokeir","doi":"10.1097/CU9.0000000000000065","DOIUrl":"10.1097/CU9.0000000000000065","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate the urinary kidney injury molecule-1 (KIM-1) as a predictor for early detection of acute kidney injury in cases with obstructive nephropathy in an animal model and to correlate urinary KIM-1 with the progress of obstructive nephropathy on a histopathological basis.</p><p><strong>Materials and methods: </strong>Three models of obstruction were induced in 90 male rats: unilateral partial ureteral obstruction with a normal contra-lateral kidney, with nephrectomy of a contralateral kidney (solitary kidney), and bilateral partial ureteral obstruction. Each group was further divided into 2 subgroups; the sham-group (10 rats) and the disease group (20 rats). Serum creatinine, blood urea nitrogen, and urinary KIM-1 were collected on days 0, 7, and 14. Rats were sacrificed on the 7th and 14th day for histopathological examination of the obstructed kidney.</p><p><strong>Results: </strong>By the end of first week, there was a significant rise of all biomarker levels in all groups when compared with basal levels. Similarly, biomarker levels at the 14th day were significantly higher than those obtained at the 7th day. The urinary KIM-1 level was not detected in the baseline condition. Expression of urinary KIM-1 showed a significant rise in all models ranging from 22 to 85 fold at the 7th day and even higher levels at the 14th day. Histopathological examination confirmed the presence of different forms of tubular injury.</p><p><strong>Conclusions: </strong>Urinary KIM-1 is significantly elevated in obstructive uropathy. Such an elevation might be advantageous in the early diagnosis and subsequent early intervention of cases with partial ureteral obstruction.</p>","PeriodicalId":39147,"journal":{"name":"Current Urology","volume":" ","pages":"312-317"},"PeriodicalIF":0.9,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12004957/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46697541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Current UrologyPub Date : 2024-12-01Epub Date: 2024-06-24DOI: 10.1097/CU9.0000000000000252
Thomas Fonseka, Alberto Melchionna, Nicolo De Luyk, Vimoshan Arumuham, Simon Choong
{"title":"A contemporary step-by-step guide to performing flexible ureterorenoscopy for renal calculi.","authors":"Thomas Fonseka, Alberto Melchionna, Nicolo De Luyk, Vimoshan Arumuham, Simon Choong","doi":"10.1097/CU9.0000000000000252","DOIUrl":"https://doi.org/10.1097/CU9.0000000000000252","url":null,"abstract":"<p><p>With advancements in laser technology and urological techniques, flexible ureterorenoscopy has emerged as a vital surgical approach for managing stone disease. Various techniques can be employed to customize endourological stone treatments. Despite the continuous evolution of equipment, it remains crucial to comprehend the fundamental steps of the procedure. This paper offers a comprehensive step-by-step guide that integrates the latest advancements in both scopes and lasers. Additionally, it outlines potential pitfalls and strategies to circumvent them, aiming to achieve optimal stone clearance and deliver individualized patient care safely and efficiently.</p>","PeriodicalId":39147,"journal":{"name":"Current Urology","volume":"18 4","pages":"265-267"},"PeriodicalIF":0.9,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12004956/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144044674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}